Literature DB >> 20573810

Identification of cross-reactive norovirus CD4+ T cell epitopes.

Anna D LoBue1, Lisa C Lindesmith, Ralph S Baric.   

Abstract

Immune responses and the components of protective immunity following norovirus infection in humans are poorly understood. Although antibody responses following norovirus infection have been partially characterized, T cell responses in humans remain largely undefined. In contrast, T cells have been shown to be essential for viral clearance of mouse norovirus (MNV) infection. In this paper, we demonstrate that CD4(+) T cells secrete gamma interferon (IFN-gamma) in response to stimulation with MNV virus-like particles (VLPs) after MNV infection, supporting earlier reports for norovirus-infected mice and humans. Utilizing this model, we immunized mice with alphavirus vectors (Venezuelan equine encephalitis [VEE] virus replicon particles [VRPs]) expressing Norwalk virus (NV) or Farmington Hills virus (FH) virus-like particles to evaluate T cell epitopes shared between human norovirus strains. Stimulation of splenocytes from norovirus VRP-immunized mice with overlapping peptides from complete libraries of the NV or FH capsid proteins revealed specific amino acid sequences containing T cell epitopes that were conserved within genoclusters and genogroups. Immunization with heterologous norovirus VRPs resulted in specific cross-reactive IFN-gamma secretion profiles following stimulation with NV and FH peptides in the mouse. Identification of unique strain-specific and cross-reactive epitopes may provide insight into homologous and heterologous T cell-mediated norovirus immunity and provide a platform for the study of norovirus-induced cellular immunity in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573810      PMCID: PMC2919024          DOI: 10.1128/JVI.00727-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Identification of an epitope common to genogroup 1 "norwalk-like viruses".

Authors:  A D Hale; T N Tanaka; N Kitamoto; M Ciarlet; X Jiang; N Takeda; D W Brown; M K Estes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.

Authors:  Sangeeta B Periwal; Kristin R Kourie; Nandini Ramachandaran; Susan J Blakeney; Sylvia DeBruin; Duzhang Zhu; Timothy J Zamb; Larry Smith; Steve Udem; John H Eldridge; Khushroo E Shroff; Patricia A Reilly
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

3.  Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France.

Authors:  Béatrice Nicollier-Jamot; Valérie Pico; Pierre Pothier; Evelyne Kohli
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 4.  Alphavirus replicon particles as candidate HIV vaccines.

Authors:  Nancy L Davis; Ande West; Elizabeth Reap; Gene MacDonald; Martha Collier; Sergey Dryga; Maureen Maughan; Mary Connell; Chris Walker; Kathryn McGrath; Chad Cecil; Li-Hua Ping; Jeff Frelinger; Robert Olmsted; Paula Keith; Ronald Swanstrom; Carolyn Williamson; Philip Johnson; David Montefiori; Robert E Johnston
Journal:  IUBMB Life       Date:  2002 Apr-May       Impact factor: 3.885

5.  A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly.

Authors:  Kim Y Green; Gaël Belliot; Jean Lin Taylor; José Valdesuso; Judy F Lew; Albert Z Kapikian; Feng-Ying C Lin
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

6.  Structural requirements for the assembly of Norwalk virus-like particles.

Authors:  Andrea Bertolotti-Ciarlet; Laura J White; Rong Chen; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice.

Authors:  Patrick R Harrington; Lisa Lindesmith; Boyd Yount; Christine L Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons.

Authors:  Ralph S Baric; Boyd Yount; Lisa Lindesmith; Patrick R Harrington; Shermalyn R Greene; Fan-Chen Tseng; Nancy Davis; Robert E Johnston; David G Klapper; Christine L Moe
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels.

Authors:  Tibor Farkas; Scott A Thornton; Nouansy Wilton; Weiming Zhong; Mekibib Altaye; Xi Jiang
Journal:  J Infect Dis       Date:  2002-12-30       Impact factor: 5.226

View more
  15 in total

1.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Authors:  Maria Malm; Kirsi Tamminen; Suvi Lappalainen; Hanni Uusi-Kerttula; Timo Vesikari; Vesna Blazevic
Journal:  Clin Vaccine Immunol       Date:  2015-04-22

3.  Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy.

Authors:  Ryo Hanajiri; Gelina M Sani; Devin Saunders; Patrick J Hanley; Abha Chopra; Simon A Mallal; Stanislav V Sosnovtsev; Jeffrey I Cohen; Kim Y Green; Catherine M Bollard; Michael D Keller
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226

4.  Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.

Authors:  Yuanmei Ma; Jianrong Li
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.

Authors:  Kirsi Tamminen; Leena Huhti; Tiia Koho; Suvi Lappalainen; Vesa P Hytönen; Timo Vesikari; Vesna Blazevic
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

6.  Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.

Authors:  Kari Debbink; Eric F Donaldson; Lisa C Lindesmith; Ralph S Baric
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

7.  Polyvalent complexes for vaccine development.

Authors:  Leyi Wang; Pengwei Huang; Hao Fang; Ming Xia; Weiming Zhong; Monica M McNeal; Xi Jiang; Ming Tan
Journal:  Biomaterials       Date:  2013-03-15       Impact factor: 12.479

8.  Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.

Authors:  Vesselin T Tomov; Lisa C Osborne; Douglas V Dolfi; Gregory F Sonnenberg; Laurel A Monticelli; Kathleen Mansfield; Herbert W Virgin; David Artis; E John Wherry
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 9.  Norovirus vaccines: Correlates of protection, challenges and limitations.

Authors:  Nada M Melhem
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

10.  Norovirus P particle efficiently elicits innate, humoral and cellular immunity.

Authors:  Hao Fang; Ming Tan; Ming Xia; Leyi Wang; Xi Jiang
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.